Beruflich Dokumente
Kultur Dokumente
Student Startup
Horizon Student Investment Competition winner on road to success
Up and Coming
New technologies coming out of UT System institutions
UTweet
15 UT System Institutions, 16 twitter feeds to follow
Welcome to Horizons, a publication of The University of Texas System Office of Technology Commercialization (OTC) that celebrates the discovery accomplishments of our 15 universities and academic health centers. Every day at UT brings a new story of accomplishment. Through our lens you will be delighted by the truly remarkable research ranging from engineering, health care, physical and biological sciences, informatics and nanotechnology. Planting research seeds and growing them into commercial products that benefit the public is easily the most challenging aspect of the discovery life cycle. Thats why Horizons is essential reading if you wish to understand how drugs are born, energy is greening up, big data is moving and much, much more. This issue also highlights the strong accomplishments of the UT System OTC. The UT Horizon Fund was reauthorized for an additional $12.5 million by the UT System Board of Regents in February. To better understand campus needs in advancing technology commercialization, OTC conducted a systemwide appraisal and also a back-testing model to quantify potential return on investments for UT startups. Results have been incorporated into new Horizon Fund directions. The 2013 student investment competition was a huge success, where 16 student teams from across UT System institutions competed for up to $100,000 in funds. It is also my great pleasure to bring OTC into central focus as the office takes on a new direct reporting relationship to me as vice chancellor of research and innovation. All of these events open new avenues that promote technology commercialization and spotlight the UT Systems commitment to this vital and innovative enterprise.
B R YA N A L L I N S O N Executive Director Office of Technology Commercialization
CONTENTS
On The Horizon
1 4
ABOUT HORIZONS
Horizons is published by the Office of Technology Commercialization (OTC) at The University of Texas System. Horizons is dedicated to showcasing the newest developments in technology commercialization at the UT System, as well as detailing new ventures coming from within the OTC. For additional information about Horizons or its contents, contact us via email at otc@utsystem.edu.
In Brief 2 Just a Little is Enough New Clean Water Filtering Method 6 Technology Showcase UT System on Twitter
8 10
Stampede uses Dells Scorpion chassis to store the supercomputers processors, enabling indvidual components to be removed and maintained without the entire system needing to be shut down.
which we collaborate extensively, is a major reason why I love coming into work, Jeet says.
HORIZONS HORIZONS
IN BRIEF
Nanofibers may be small it takes 1,000 nanofibers to equal the thickness of a single human hair but boy do they have might. Nanofibers have a host of properties that make them superior to almost every other material available today. With a dramatically higher surface-area-tovolume ratio, up to 1,000 times higher than microfibers, nanofibers are far more efficient than most commonly used fibers when it comes to applications such as chemical delivery, electron and photon transfer, and filtration. They have fantastic tensile strength, increased resistance to cracking and much improved thermal and electrical properties over their microfiber counterparts.
Forcespinning technology allows for industrial scale production of nanofibers in a process that is more versatile, efficient, cost-effective and safe than any other process in use today. Our competitors combine electricity with dangerous solvents to make nanofibers, explains Buchanan. We simply use centrifugal force, like cotton candy, so we can make the fibers with or without solvents. This means that Forcespinning has ten times the productivity, is one quarter of the cost and is environmentally friendly. Combine FibeRios revolutionary Forcespinning technology
From healthcare to energy, textiles to water filtration, nanofiber applications are limitless. Just ask Ellery Buchanan, President and CEO of FibeRio Technology Corporation, a developer and manufacturer of nanofiber production systems.
with other rapidly occurring innovations in the field of nanotechnology and the world is poised to see not only the rise of a multi-billion dollar industry, but unprecedented, widespread implementation of nanofibers in products and applications. Nanotechnology is the science of the small, but the opportunity is very big. It has been estimated that the total impact of nanotechnology could soon be over $200 billion. Nanofibers are one piece of that puzzle. And, it is estimated that the market will be several billion dollars by 2020, Buchanan said. FibeRio is set to have a major influence on this untapped market. Coming out of UTPA and with offices located in Edinburg, Texas, FibeRio looks to not only expand its own capabilities to keep up with the increasing demand for nanofibers, but to put South Texas on the map of advanced nanotechnology producers. FibeRio will continue to expand the productivity and size of our equipment very rapidly, Buchanan said. We will
enable huge advancements in filtering the air we all breathe and even the water we drink, in the clothes we wear and in the power that drives our daily lives. Some of this innovation is occurring right here with our research partners in the UT System, and we are proud of the opportunities we have to give back to this great state through jobs, commerce and service. Keep an eye out for products incorporating nanofibers
Nanofibers will be used for everything from air filters to wound bandages, from aerospace composites to batteries, and from diapers to clothing, said Buchanan. In the nearest coming years it will be surgical gowns and air filters. Then it will expand to clothing and energy. While the uses for nanofibers may be limitless, producing them in large quantities has proven difficult and expensive. Enter FibeRio. Co-founded in 2009 with The University of Texas Pan American (UTPA), FibeRios breakthrough
produced by companies like FibeRio in the near future. As proliferation of technologies such as FibeRios spread, nanofibers are destined to become the material of choice for crafting products we use in our everyday lives, for every purpose that can be imagined.
HORIZONS HORIZONS
UTSA grads innovative aneurysm repair gets it right the first time
An estimated 1.2 million people in the U.S. have some form of abdominal aortic aneurysm (AAA) every year when the large blood vessel (aorta) that supplies blood to the abdomen, pelvis and legs becomes abnormally large or balloons outward. Current procedures to repair AAA end up leaking 17 percent of the time, warranting costly secondary surgeries or interventions. By facilitating natural healing, the TESAR But not for long thanks to Dr. Jordan Kaufmann, Biomedical Engineering Ph.D. graduate of The University of Texas at San Antonio (UTSA) and 2012 winner of the first annual University of Texas Horizon Fund Student Investment Competition (SIC). Kaufmann, who was awarded a $50,000 grant, will use the money to support Cardiovate, a startup company dedicated to the development of a new stent-graft that vastly improves treatment of AAA. Dr. Kaufmanns research has focused on replacing current synthetic graft material with tissue engineering scaffold for aneurysm repair (TESAR). Current stent-grafts are made of Teflon or other polymers that dont actually cause the aneurysm to heal. The TESAR
scaffold promotes a tissue barrier at the site of the aneurysm. Once the barrier is established, the TESAR bioresorbs into the body. Current methods for treating an aneurysm dont promote healing and can leak, said Dr. Kaufmann. The TESAR stent-graft heals the aneurysm instead of just covering it up.
While Cardiovate has a promising future, participation in the Horizon competition has its benefits too. Competing in the SIC prompted me to organize my business plan and think about the direction I wanted my company to take, Dr. Kaufmann said. The requirements of the SIC helped me to do the groundwork for the company and to visualize how Cardiovate would be brought to life. While theres much work to be done, Dr. Kaufmanns committed to bringing TESAR to market.
stent-graft reduces the need for secondary surgeries and interventions, which reduces healthcare costs and improves patient outcomes. After six years of developing TESAR technology in the lab, Dr. Kaufmann decided to commercialize her technology. Coming from a medical background, many of the business aspects of starting my own company post new challenges, said Dr. Kaufmann. More logistical than anything else, the company side of getting our technology to market is a new adventure. In addition to raising additional funds to help Cardiovate take off, Dr. Kaufmann is working on scaling her TESAR technology for commercial manufacturing. Were looking to have our first human trial within 2 years, said Dr. Kaufmann. If that goes well, we are going to try to make it into the European market in 5-6 years. If we are successful there, hopefully our technology will be the new industry standard for treating aneurysms. We see our technology as a next generation graft that will push the market up.
Just a Little is Enough: Apollo Endosurgery Envisions A Painless Future For Surgeries
Pain, hospital stay, risk of infection, scarring. They go hand-in-hand with any invasive surgical procedure, and demand careful management from medical and hospital staff, and endurance and self-care from the patient. What if there was a way to perform surgery that was less invasive that was not only less traumatic for patients but more efficient and effective too? Until recently, the technology to perform complex surgeries without external incisions did not exist. But the emerging field of endosurgery minimally invasive surgery is about to change all that, and Apollo Endosurgery, Inc. is helping to lead the way. Founded in 2006 on initial groundwork of the Apollo Group, a conglomerate of gastroenterologists and surgeons from the Mayo Clinic, Johns Hopkins, the Medical University of South Carolina, The University of Texas Medical Branch at Galveston (UTMB) and the Chinese University of Hong Kong, Apollo Endosurgerys goal is to advance the field of endosurgery and less invasive therapies through cutting-edge research and development, and commercialization of the groups inventions and innovations. In fact, the devices used in endosurgeries give this developing field incalculable potential. Apollo and other venture-backed startup companies are leading the efforts in developing new technologies in this space, said Dennis McWilliams, CEO and founder of Apollo. Traditionally, smaller companies have been the birthplace of innovation in life sciences. Its typically not until a new technology has been through the gauntlet of regulatory approval, proof of concept and early commercialization that larger companies take on the marketing and sales of these innovations. The OverStitch suturing system and OverTube endoscopic access system are Apollos two flagship products. OverStitch allows doctors to suture incisions precisely through a single insertion of the endoscope. The OverTube is a sheath placed around the endoscope during surgeries that protects both the device and the patient. Not one to rest on its laurels, Apollo is focused on expanding their product line to include more affordable and innovative endoscopic developments. Our niche is in flexible, disposable, cost-effective surgical tools H O R I that Z O N S fit on or through a flexible endoscope, said
HORIZONS
McWilliams. Additionally, energy-based therapies are also of interest to us. Apollo is currently developing the SuMO tissue access system, which will allow doctors to treat suspicious lesions of greater size endoscopically, an alternative to highly-invasive procedures that can lead to digestive complications and fatalities. As innovations in the field of endosurgery evolve, so will its applications and reach. In fact, when it comes to making non-invasive surgery available to more people, the envelope is constantly being pushed. Dennis McWilliams predicts that up one third of surgical procedures will be performed through less invasive means over the next decade. Its a trend that spells booming business for companies like Apollo, enabling its founder to bring his companys vision to life. We want to revolutionize patient care by driving the adoption of endoscopic therapy, said McWilliams. Initially, we focused on patients that were too sick for normal surgery, and flexible endoscopic surgery offered the only option to solve a gastrointestinal problem. Increasingly we are treating a broader range of patients from the very sick to patients who simply want a less invasive option for their therapy. The innovations of Apollo are helping to elevate endosurgery within the field of medicine. However, innovations as vast as theirs are not always readily adopted. One of the major challenges facing industry leaders like Dennis McWilliams is raising awareness of the benefits that the endoscopic route can bring to the operating table. Many people dont realize that endoscopic alternatives are available for many procedures right now, today, said McWilliams. As people become aware of the option to reduce pain, hospital stays and scarring, endoscopic alternatives are bound to catch on.
Above: The OverStitch system allows for quick and precise sutures while subjecting the patient to minimal amounts of trauma
The availability of an
instrument capable of detecting several agents simultaneously would greatly enhance our response to a possible bioterror attack or the emergence of a disease not often seen here
- Richard Wilson
Lead Researcher, University of Houston
The retroreflector technology used to create safety reflectors for bicycles, running shoes and apparel may soon be used to detect bioterror threats and aid emergency response crews in their efforts to identify agents used in a biological attack. Led by Richard Willson of the University of Houston, scientists from The University of Texas Medical Branch at Galveston and Sandia National Laboratories in California have developed an ultrasensitive, all-in-one device that utilizes retroreflector technology to quickly tell first responders exactly which diseasecausing microbe has been used in a bioterrorism attack. In the most likely kind of attack, large numbers of people would start getting sick with symptoms that could be from multiple infectious agents. But which one? Willson said. The availability of an instrument capable of detecting several agents simultaneously would greatly enhance our response to a possible bioterror attack or the emergence of a disease not often seen here. Retroreflectors have been around for a long time and are ubiquitous
in things like street signs, safety vests and traffic lane markers. The Apollo 11 astronauts even left a retroreflector on the moon that is still used today as a laser-range finder. Wilson and his colleagues have modified the retroreflectors by decreasing their size so that 200 of them would fit inside the period at the end of this sentence. These microfabricated retroreflectors were given a biochemical surface capable of detecting pathogens, essentially turning them into a mini lab-on-a-chip, with minute channels that can process small amounts of blood or other fluids. If a sample of blood or fluid is bacteria-free, the reflector shines brightly. A sample containing pathogens, however, blocks out some reflectors and makes them go dark. The advantages of this technology are many, with instant feedback, universal application, low cost and accuracy topping the list. Ultimately, it could help save lives. Currently, the device can test on seven different channels at once, with each channel targeting a different type of disease. The researchers aim to continue
adding channels to making their retroreflectors a one-stop diseasetesting tool. Willson and his colleagues have proposed an alternative that could provide more immediate results and one that could be small enough to be carried by first responders or doctors. The team is also modifying the technology for use in doctors offices and clinics where retroreflectors could provide rapid, on-site diagnoses of common infectious diseases before patients leave, eliminating the wait for test results and expediting treatment. The retroreflector device has already proven successful in identifying a bioterrorism threat that causes Mediterranean spotted fever, and more tests are soon to come.
HORIZONS HORIZONS
Many countries, including the U.S., use ground water as their primary drinking source. Unfortunately, ground water is susceptible to contamination from leaking sewer lines and septic tanks, infiltration of surface water contaminated by human and animal wastes, and careless disposal of septic waste. The pathogens and bacteria in contaminated drinking water can lead to hepatitis viruses and E. coli bacteria, which pose serious health and financial costs. Blocking transmission of these pathogens and bacteria to humans could significantly reduce disease outbreaks associated with groundwater as well as alleviate concerns regarding bioterrorist threats to drinking water supplies. The Surfactant Modified Zeolite (SMZ) filter is designed to do just that. Developed by The University of Texas at El Paso (UTEP) researchers Dirk Schulze-Makuch, Robert Bowman and Natesh Pillai, the SMZ filter provides an inexpensive and highly effective method to remove biological pathogens including bacteria, viruses and parasitic protozoa from water. The SMZ filter can be deployed in many different applications. Potable water filters, point of use water filters, water bottle filters or filter packets that can be placed into a body of water such as a well or pond, are all potential uses. This highly flexible property makes the SMZ filter ideal for areas that have multiple water sources in need of purification as well as regions where reliable access to clean water is not available. In addition to being extremely versatile, the SMZ filter is also inexpensive to produce at only about 50 cents per pound, and used for any types of water ranging from drinking water to waste water. These properties, combined with the ability to manufacture in various grain sizes to allow water to flow at reasonably fast discharge rates, makes the SMZ filter a prime choice for any application. The SMZ filter has been tested in both laboratory and field experiments and has shown to be extremely efficient in removing bacteria and viruses from water. In field experiments on sewage water, the SMZ filter removed 100 percent of E. coli and more than 99.9 percent of the bacteriophages tested. After six months the removal efficiency for E. coli was still 100 percent. The SMZ filter holds tremendous potential for ensuring clean water, essential to public health and society as a whole.
science education programs and constructing technological systems and infrastructure for the mission of discovery.
The benefits of commercialization extend past research and into community, Dr. Hurn said. We have a strong responsibility to our community, our students and patients to carry research to this next step in what many refer to as the discovery life cycle. The Horizon Fund was created to meet that responsibility and that vision is evident in its investment design.
Slimmer, sleeker, tinier, with increased, long-lasting functionality thats the name of the game when it comes to the future of mobile device design. But keeping up with these demands has its limitations. And time is running out.
THE TECH: Cell phones, MP3 players, digital cameras and the like use non-volatile flash memory electronically erasable programmable read-only memory (EEPROM) that maintains stored information without requiring a power source. But loading up ever-shrinking devices with more and more features requires more power. The problem is that current flash memory technology, specifically its fabrication and materials, is reaching the limits of its ability to shrink down to the size needed to keep pace with evolving technology. Striking a balance between flash memory technology and future mobile device design has been a constant struggle for engineers. But researchers at The University of Texas at Austin, Department of Electrical and Computer Engineering Microelectronics Research Center may have the answer. The new channel material and new channel design also reduce the energy required for programming. The combined result is a new flash memory cell capable of fast programming under low voltage and/or low power operating conditions with a much lower failure rate. Through the use of new materials, UT Austin researchers can continue to scale down flash memory to meet lower power demands. A new design featuring an array of quantum dots tiny or nanosized semiconductors combined with a new tunneling layer material enables flash memory devices to use very low amounts of power while being able to store data without significant levels of leakage.
T H E TA R G E T:
While this new flash memory technology is still in its proof of concept stage, all signs point to commercialization. When you consider the worlds estimated six billion cell phone subscribers, according to a recent United Nations study, and sale of tens of millions of MP3 players and digital cameras each year (both slowly being taken over by smartphones), this new technology will arrive none too soon. In fact, it would be easier to identify people who wont be using this technology than it would be to define its target market. While cell phones, digital cameras and MP3 players are some of the most widely used consumer items that will benefit from this technology, literally any electronic device that uses flash memory has the potential to be enhanced. For example, image acquisition and semiconductor laser technologies would benefit from higher resolution that the quantum dot array can provide. Perhaps the most important benefit this technology provides is making electronic mobile devices more accessible to those who cannot afford or do not have reliable access to power. Because faster, more efficient devices require less time plugging in and charging up, more people will be able to connect, play, learn, see and do more.
HORIZONS HORIZONS
TECHNOLOGY Showcase
Medical devices such as urinary catheters, endotracheal tubes and central venous catheters are the leading cause of hospital-acquired infections in high-risk patients. Data shows that 300,000 cases of nosocomial (hospitalacquired) pneumonias occur annually in the U.S. Dr. Issam Raad of UT MD Anderson may have found a solution.
THE TECH:
T H E TA R G E T:
Almost 50 million surgeries are performed in the U.S. every year. The amount of people that could benefit from Dr. Raad and his fellow researchers innovation is significant. In addition to benefit surgical patients, antimicrobial coating could be instrumental in saving the lives of people in developing countries. Doctors concerned about performing procedures in an unsterile environment now have an effective method to prevent infection. Dr. Raads team has developed 33 issued inventions, with 16 additional patents. These include vascular catheters, urinary catheters and endotracheal tubes.
HORIZONS HORIZONS
TECHNOLOGY Showcase
9
UT MD Anderson researcher invents method to make sure that sterile surgical tools stay clean
The UT System on
twitter.com/UTInnovations
UT ARLINGTON
O N T WI T T E R :
UT EL PASO
ON TW ITTER :
@UTArlington
@utepnews
UTA receives $7.5 million donation from Japanbased Shimadzu Scientific Instruments, the largest philanthropic donation in the history of the university
High-performance computing gets a new home in West Texas as the Research and Academic Data Center moves into its new home at UTEP
UT AUSTIN
O N T WI T T E R :
UT PAN AMERICAN
ON TW ITTER :
@UTAustin
@UTPA
The University of Texas at Austin has been ranked 27th in the 2013 Times Higher Education World Rankings- a five-point climb from its 32nd ranking in 2012
UTPAs College of Health Sciences and Human Services looks to engage the community by distributing health education material at public gatherings
UT BROWNSVILLE
O N T WI T T E R :
@UTBrownsville
UT PERMIAN BASIN
ON TW ITTER :
@utpb
Support continues to grow in the legislature to open the Permanent University Fund endowment to UT Brownsville and UT Pan American
UTPB Womens basketball team are once again the Hearthland Conference champions and are ranked #5 in the NCAA South Central region
UT DALLAS
O N T WI T T E R :
@UT_Dallas
UT SAN ANTONIO
ON TW ITTER :
@UTSanantonio
UTDs 12th annual ChessFest allows students to play against two blindfolded grandmasters (the highest ranking possible) from the UTD chess team
The UTSA Honors College raised $161,765 for student scholarships, research stipends and other applications at the 2013 Great Conversation!
UT TYLER
ON TW ITTER :
@UTMB_news
@UTTyler
An FDA-approved drug intended to treat insulin resistance in diabetics has been shown to improve memory in people with Alzheimers disease
UT Tyler biology department awarded $70,000 from the Texas Parks and Wildlife department to study endangered species of mussels in Texas
@UThealth
@uthscsa
Doctors at UT Health propose a study to evaluate the treatment of traumatic head injuries, as current treatments have a fatality rate of up to 70%
UTHSCSA researchers discover a link between insulin sensitivity and cells energy sources, a link that could one day be exploited to treat type 2 diabetes
UT MD ANDERSON
O N T WI T T E R :
@MDAndersonNews
@UTSWnews
UT MD Anderson doctors find that cancer vaccinations actually sabotage the immune system, causing T cells to attack the vaccination site, not the tumors
A study led by UTSW professor Beth Levine shows that augmenting the bodys innate ability to rid itself of cell waste could defend against West Nile
UT SYSTEM
O N T WI T T E R :
@UTsystem
@UTHSCT
#UTSystem regents approve guiding principles for new university in the RGV . #ProjectSouthTX
Lawmakers are debating state funding of cancer research, $37 million of which UTHSCT receives annually